200405

A phase II, randomized, placebo-controlled study of the immunogenicity, safety and reactogenicity of an orally administered human rotavirus vaccine (RIX4414) in healthy infants in Bangladesh.

Short Title Rotavirus vaccine i n Bangladesh
Protocol No 200405
Status Completed
Keywords VACCINE, ROTAVIRUS, IMMUNOGENICITY, REACTOGENICITY, DIARROHOEA, BANGLADESH
Center Public Health Sciences
MDG(s) this protocol relates to
HPNSDP(s) this protocol relates to
PI Name Md. Khalequzzaman
Collaborating Institutes (019) Centers for Disease Control and Prevention, USA
(145) University of Cincinnati, Ohio
Funding
Summary
‹ Search All Protocols Here